Texas Top Legal Officer Sues Tylenol Makers Concerning Autism Spectrum Claims

Legal Action
Ken Paxton, who supports former President Trump who is running for the United States Senate, claimed the drug companies of hiding safety concerns of Tylenol

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of Tylenol, asserting the companies withheld alleged dangers that the medication posed to children's cognitive development.

This legal action follows a month after President Donald Trump promoted an unsubstantiated connection between consuming Tylenol - alternatively called paracetamol - while pregnant and autism in children.

Paxton is suing J&J, which once produced the medication, the exclusive pain medication recommended for expectant mothers, and the current manufacturer, which currently produces it.

In a declaration, he claimed they "misled consumers by making money from discomfort and pushing pills regardless of the risks."

Kenvue says there is insufficient reliable data connecting acetaminophen to autism.

"These companies deceived for years, deliberately risking millions to increase profits," Paxton, from the Republican party, said.

The manufacturer said in a statement that it was "very worried by the spread of false claims on the safety of acetaminophen and the potential impact that could have on the welfare of US mothers and children."

On its website, Kenvue also said it had "continuously evaluated the pertinent research and there is lacking reliable evidence that shows a proven link between taking acetaminophen and autism."

Organizations speaking for doctors and medical practitioners agree.

ACOG has stated acetaminophen - the primary component in Tylenol - is a restricted selection for expectant mothers to address discomfort and elevated temperature, which can create major wellness concerns if not addressed.

"In over twenty years of studies on the use of paracetamol in pregnancy, zero credible investigations has successfully concluded that the use of acetaminophen in any period of pregnancy causes brain development issues in children," the association stated.

This legal action cites recent announcements from the previous government in asserting the medication is allegedly unsafe.

In recent weeks, Trump raised alarms from health experts when he advised expectant mothers to "fight like hell" not to use Tylenol when ill.

Federal regulators then published an announcement that medical professionals should think about restricting the usage of acetaminophen, while also declaring that "a direct connection" between the drug and autism in children has not been proven.

The Health Department head RFK Jr, who oversees the Food and Drug Administration, had promised in April to conduct "a massive testing and research effort" that would establish the source of autism in a limited time.

But experts cautioned that finding a sole reason of autism spectrum disorder - believed by scientists to be the result of a complex mix of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a category of lifelong neurodivergence and condition that affects how individuals experience and interact with the world, and is diagnosed using physician assessments.

In his court filing, the attorney general - who supports Trump who is campaigning for the Senate - claims the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the research" around paracetamol and autism spectrum disorder.

The lawsuit attempts to require the corporations "eliminate any marketing or advertising" that states Tylenol is safe for expectant mothers.

This legal action echoes the grievances of a assembly of guardians of children with autism and attention deficit hyperactivity disorder who sued the makers of Tylenol in two years ago.

Judicial authorities rejected the case, stating research from the family's specialists was inconclusive.

Katelyn Salinas
Katelyn Salinas

Elara is a digital storyteller and narrative designer with a passion for crafting immersive experiences that blend technology and creativity.